vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $173.1M, roughly 1.2× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 1.1%, a 19.2% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $-26.8M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

CASH vs VREX — Head-to-Head

Bigger by revenue
VREX
VREX
1.2× larger
VREX
$209.6M
$173.1M
CASH
Growing faster (revenue YoY)
VREX
VREX
+5.1% gap
VREX
4.9%
-0.2%
CASH
Higher net margin
CASH
CASH
19.2% more per $
CASH
20.3%
1.1%
VREX
More free cash flow
CASH
CASH
$130.9M more FCF
CASH
$104.1M
$-26.8M
VREX
Faster 2-yr revenue CAGR
VREX
VREX
Annualised
VREX
0.8%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CASH
CASH
VREX
VREX
Revenue
$173.1M
$209.6M
Net Profit
$35.2M
$2.3M
Gross Margin
33.3%
Operating Margin
24.6%
7.3%
Net Margin
20.3%
1.1%
Revenue YoY
-0.2%
4.9%
Net Profit YoY
11.9%
866.7%
EPS (diluted)
$1.57
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
VREX
VREX
Q1 26
$209.6M
Q4 25
$173.1M
$228.9M
Q3 25
$186.7M
$203.0M
Q2 25
$195.8M
$212.9M
Q1 25
$274.8M
$199.8M
Q4 24
$182.6M
Q3 24
$179.5M
$205.7M
Q2 24
$188.6M
$209.1M
Net Profit
CASH
CASH
VREX
VREX
Q1 26
$2.3M
Q4 25
$35.2M
$12.2M
Q3 25
$38.8M
$-89.1M
Q2 25
$42.1M
$6.9M
Q1 25
$75.0M
$-300.0K
Q4 24
$30.0M
Q3 24
$33.5M
$-51.1M
Q2 24
$44.9M
$1.4M
Gross Margin
CASH
CASH
VREX
VREX
Q1 26
33.3%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
36.0%
Q1 25
34.3%
Q4 24
Q3 24
32.6%
Q2 24
32.0%
Operating Margin
CASH
CASH
VREX
VREX
Q1 26
7.3%
Q4 25
24.6%
8.6%
Q3 25
25.9%
-39.8%
Q2 25
24.1%
10.4%
Q1 25
33.2%
5.6%
Q4 24
19.8%
Q3 24
20.9%
5.3%
Q2 24
27.1%
4.4%
Net Margin
CASH
CASH
VREX
VREX
Q1 26
1.1%
Q4 25
20.3%
5.3%
Q3 25
20.8%
-43.9%
Q2 25
21.5%
3.2%
Q1 25
27.3%
-0.2%
Q4 24
16.4%
Q3 24
18.7%
-24.8%
Q2 24
23.8%
0.7%
EPS (diluted)
CASH
CASH
VREX
VREX
Q1 26
$0.05
Q4 25
$1.57
$0.29
Q3 25
$1.69
$-2.15
Q2 25
$1.81
$0.17
Q1 25
$3.14
$-0.01
Q4 24
$1.23
Q3 24
$1.34
$-1.25
Q2 24
$1.78
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$331.2M
$125.6M
Total DebtLower is stronger
$33.5M
$367.6M
Stockholders' EquityBook value
$854.5M
$476.9M
Total Assets
$7.6B
$1.1B
Debt / EquityLower = less leverage
0.04×
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
VREX
VREX
Q1 26
$125.6M
Q4 25
$331.2M
$155.1M
Q3 25
$120.6M
$152.6M
Q2 25
$258.3M
$223.0M
Q1 25
$254.2M
$212.6M
Q4 24
$597.4M
Q3 24
$158.3M
$200.5M
Q2 24
$298.9M
$190.0M
Total Debt
CASH
CASH
VREX
VREX
Q1 26
$367.6M
Q4 25
$33.5M
$367.5M
Q3 25
$33.5M
$367.5M
Q2 25
$33.4M
$567.2M
Q1 25
$33.4M
$567.0M
Q4 24
$33.4M
Q3 24
$33.4M
$443.4M
Q2 24
$33.3M
$443.1M
Stockholders' Equity
CASH
CASH
VREX
VREX
Q1 26
$476.9M
Q4 25
$854.5M
$472.6M
Q3 25
$858.0M
$455.3M
Q2 25
$819.0M
$549.7M
Q1 25
$814.7M
$540.2M
Q4 24
$758.3M
Q3 24
$822.5M
$529.1M
Q2 24
$748.4M
$581.2M
Total Assets
CASH
CASH
VREX
VREX
Q1 26
$1.1B
Q4 25
$7.6B
$1.1B
Q3 25
$7.2B
$1.1B
Q2 25
$7.2B
$1.4B
Q1 25
$7.0B
$1.3B
Q4 24
$7.6B
Q3 24
$7.5B
$1.2B
Q2 24
$7.5B
$1.3B
Debt / Equity
CASH
CASH
VREX
VREX
Q1 26
0.77×
Q4 25
0.04×
0.78×
Q3 25
0.04×
0.81×
Q2 25
0.04×
1.03×
Q1 25
0.04×
1.05×
Q4 24
0.04×
Q3 24
0.04×
0.84×
Q2 24
0.04×
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
VREX
VREX
Operating Cash FlowLast quarter
$108.3M
$-16.1M
Free Cash FlowOCF − Capex
$104.1M
$-26.8M
FCF MarginFCF / Revenue
60.1%
-12.8%
Capex IntensityCapex / Revenue
2.4%
5.1%
Cash ConversionOCF / Net Profit
3.08×
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$616.8M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
VREX
VREX
Q1 26
$-16.1M
Q4 25
$108.3M
$7.9M
Q3 25
$303.7M
$7.7M
Q2 25
$30.4M
$16.6M
Q1 25
$188.3M
$9.5M
Q4 24
$-71.7M
Q3 24
$143.1M
$25.9M
Q2 24
$113.2M
$8.0M
Free Cash Flow
CASH
CASH
VREX
VREX
Q1 26
$-26.8M
Q4 25
$104.1M
$2.3M
Q3 25
$300.3M
$1.4M
Q2 25
$27.7M
$9.8M
Q1 25
$184.7M
$5.3M
Q4 24
$-73.8M
Q3 24
$138.8M
$19.9M
Q2 24
$111.0M
$3.3M
FCF Margin
CASH
CASH
VREX
VREX
Q1 26
-12.8%
Q4 25
60.1%
1.0%
Q3 25
160.9%
0.7%
Q2 25
14.1%
4.6%
Q1 25
67.2%
2.7%
Q4 24
-40.4%
Q3 24
77.3%
9.7%
Q2 24
58.8%
1.6%
Capex Intensity
CASH
CASH
VREX
VREX
Q1 26
5.1%
Q4 25
2.4%
2.4%
Q3 25
1.8%
3.1%
Q2 25
1.4%
3.2%
Q1 25
1.3%
2.1%
Q4 24
1.1%
Q3 24
2.4%
2.9%
Q2 24
1.2%
2.2%
Cash Conversion
CASH
CASH
VREX
VREX
Q1 26
-7.00×
Q4 25
3.08×
0.65×
Q3 25
7.83×
Q2 25
0.72×
2.41×
Q1 25
2.51×
Q4 24
-2.39×
Q3 24
4.27×
Q2 24
2.52×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons